Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 12

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

Authors Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M

Received 9 June 2016

Accepted for publication 8 July 2016

Published 22 September 2016 Volume 2016:12 Pages 2439—2448

DOI https://doi.org/10.2147/NDT.S114671

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Prof. Dr. Roumen Kirov

Peer reviewer comments 2

Editor who approved publication: Dr Roger Pinder

Ales Grambal,1 Jan Prasko,1 Dana Kamaradova,1 Klara Latalova,1 Michaela Holubova,1,2 Marketa Marackova,1 Marie Ociskova,1 Milos Slepecky3

1Faculty of Medicine and Dentistry, Department of Psychiatry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, 2Department of Psychiatry, Hospital Liberec, Liberec, Czech Republic; 3Faculty of Social Science and Health Care, Department of Psychology Sciences, Constantine the Philosopher University, Nitra, Slovak Republic

Introduction: Self-stigma arises from one’s acceptance of societal prejudices and is common in psychiatric patients. This investigation compares the self-stigma of a sample of patients with borderline personality disorder (BPD), schizophrenia spectrum disorder (SCH), major depressive disorder (MDD), bipolar affective disorder (BAD), and anxiety disorders (AD) and explores of the self-stigma with the subjective and objective measures of the severity of the disorder and demographic factors.
Methods: The total of 184 inpatients admitted to the psychotherapeutic department diagnosed with BPD, SCH, MDD, BAP, and AD were compared on the internalized stigma of mental illness (ISMI) scale. The ISMI-total score was correlated with the subjective and objective evaluation of the disorder severity (clinical global impression), and clinical and demographic factors.
Results: The self-stigma levels were statistically significantly different among the diagnostic groups (BPD 71.15±14.74; SCH 63.2±13.27; MDD 64.09±12.2; BAD 62.0±14.21; AD 57.62±15.85; one-way analysis of variance: F=8.698, df=183; P<0.005). However after applying the Bonferroni’s multiple comparison test, the only significant difference was between the BPD patients and the patients with AD (P<0.001). Stepwise regression analysis showed that the strongest factors connected with the higher level of self-stigma were being without partner, the number of hospitalization, and the severity of the disorder.
Conclusion: The BPD patients suffer from a higher level of self-stigma compared to patients with AD. In practice, it is necessary to address the reduction of self-stigma by using specific treatment strategies, such as cognitive therapy.

Keywords: self-stigma, borderline personality disorder, schizophrenia spectrum and related disorders, major depressive disorder, anxiety disorders, severity of the disorder

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Self-stigma and schizophrenia: a cross-sectional study

Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3011-3020

Published Date: 24 November 2016

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study

Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3021-3030

Published Date: 24 November 2016

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2677-2687

Published Date: 19 October 2016

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders

Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:2659-2676

Published Date: 17 October 2016

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2539-2552

Published Date: 7 October 2016

Delirium as a complication of the surgical intensive care

Horacek R, Krnacova B, Prasko J, Latalova K

Neuropsychiatric Disease and Treatment 2016, 12:2425-2434

Published Date: 22 September 2016

Quality of life in borderline patients comorbid with anxiety spectrum disorders – a cross-sectional study

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, SedlÑčkovÑ Z, Hruby R,

Patient Preference and Adherence 2016, 10:1421-1433

Published Date: 1 August 2016

Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders

Holubova M, Prasko J, Hruby R, Latalova K, Kamaradova D, Marackova M, Slepecky M, Gubova T

Patient Preference and Adherence 2016, 10:1151-1158

Published Date: 24 June 2016

Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A

Neuropsychiatric Disease and Treatment 2016, 12:1539-1551

Published Date: 24 June 2016

Unmet needs of bipolar disorder patients

Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B

Neuropsychiatric Disease and Treatment 2016, 12:1561-1570

Published Date: 24 June 2016

Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents

Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V

Neuropsychiatric Disease and Treatment 2016, 12:665-672

Published Date: 23 March 2016

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

Vyskocilova J, Prasko J, Sipek J

Neuropsychiatric Disease and Treatment 2016, 12:625-639

Published Date: 14 March 2016

Coping strategies and quality of life in schizophrenia: cross-sectional study

Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A

Neuropsychiatric Disease and Treatment 2015, 11:3041-3048

Published Date: 10 December 2015

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K

Neuropsychiatric Disease and Treatment 2015, 11:1191-1201

Published Date: 15 May 2015